NeuroMetrix to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference

NeuroMetrix, Inc. (NASDAQ:NURO) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference at the Convene Conference Center in New York, NY on February 11, 2016. Dr. Gozani intends to provide an update on the Company’s business activities including the Quell® Wearable Pain Relief Technology™.

NeuroMetrix’s presentation is scheduled for Thursday, February 11, 2016 at 9:30 a.m. Eastern time. A live audio and slide webcast will be available on the investor relations section of the corporate website, www.NeuroMetrix.com. This webcast will be archived after the live event.

About Source Capital Group

Source Capital Group, Inc. was founded in 1992 on the belief that the best investment advice should be independent, unbiased and tailor-made for the individual client’s needs. Source Capital began as a boutique investment banking firm specializing in small to medium sized transactions. It has grown to include businesses in general securities, emerging market securities, distressed and high yield debt securities, in addition to its investment banking activity. For more information, please visit http://www.sourcegrp.com/.

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

Contacts:

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.